Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high-quality treatments for patients requiring customized formulations for their care.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine that’s
RIGHT FOR OUR PATIENTS
Azurity specializes in providing safe, high quality treatments for patients requiring customized formulations for their care. Azurity focuses on the needs of patients, such as children and the elderly, requiring customized, user-friendly drug formulations.
Medicine That’s Easy to Give…
and to Take
Azurity’s products have benefited millions of patients who are unable to swallow conventional oral dosage forms, such as tablets and capsules, and whose needs are not served by other commercially available therapies.
Azurity currently offers a comprehensive product portfolio that serves multiple therapeutic areas, with more on the way!
FDA-APPROVED PRODUCTS
A growing portfolio of products designed to fulfill unmet needs of both pediatric and elderly patients.
Labels for representation purposes only
NON-FDA APPROVED FIRST® COMPOUNDING KITS
A family of prescription compounding kits designed as an alternative to conventional dosage forms.
Labels for representation purposes only
Pharmacist to Pharmacist
Click below to access our USP RESOURCES TOOLKIT to help you navigate the ever-changing <795>, <797>, and <800> USP chapters.
News & Events
Azurity Pharmaceuticals Announces Three New Neurology Products
WOBURN, Mass. (February 8, 2021) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today the purchase of the neurology portfolio from Eton Pharmaceuticals. The product portfolio includes lamotrigine (ET-105), zonisamide...
Katerzia™, the First and Only Amlodipine Oral Suspension, 1 mg/mL, is Now Commercially Available for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (September 25, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that Katerzia (amlodipine) Oral Suspension, 1 mg/mL, the first and only FDA-approved amlodipine oral suspension, is now commercially...